May. 5 at 8:38 PM
$PFE I don’t know why it’s hard to accept that this company’s new products will get approved and that will more than cover the revenue loss due to patent expiration. They invested 60B into acquiring companies with products that are in trial . Yes , some may have failed , but not all . Also remember , that 60B is in a way is profit they made out of Covid products , sort of an unexpected gift .
